Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.03
-0.14 (-2.80%)
Jun 29, 2026, 10:47 AM EDT - Market open
Lifecore Biomedical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | May '25 May 25, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 | May '21 May 30, 2021 |
Net Income | -34.08 | -38.72 | 12.01 | -99.56 | -116.72 | -32.29 |
Depreciation & Amortization | 8.2 | 8.03 | 7.95 | 13.18 | 18.06 | 19.87 |
Stock-Based Compensation | 8.09 | 10.16 | 6.2 | 3.61 | 2.61 | 3.36 |
Other Adjustments | 18.82 | 25.02 | -22.21 | 45.54 | 76.55 | 15.78 |
Change in Receivables | - | -2.26 | -3.26 | 10.82 | -6.14 | 5.78 |
Changes in Inventories | 8.66 | 7.69 | 0.86 | -14.81 | -2.18 | -2.82 |
Changes in Accounts Payable | 3.5 | -1.67 | -6.68 | 16.04 | 9.34 | -5.98 |
Changes in Accrued Expenses | -7.21 | -5.92 | 1.65 | -0.49 | -3.42 | 4.08 |
Changes in Unearned Revenue | - | - | - | 6.08 | -0.02 | 0.43 |
Changes in Other Operating Activities | 3.08 | -2.53 | 3.73 | 2.16 | -0.69 | 8.28 |
Operating Cash Flow | 15.08 | -0.21 | 0.26 | -17.44 | -22.59 | 16.47 |
Operating Cash Flow Growth | 372.51% | - | - | - | - | - |
Capital Expenditures | -8.73 | -13.42 | -18.4 | -21.48 | -29.94 | -25.22 |
Sale of Property, Plant & Equipment | - | 7 | - | - | 1.14 | 12.91 |
Proceeds from Sale of Investments | - | - | - | - | 45.1 | - |
Proceeds from Business Divestments | - | - | - | 16.67 | 63.66 | - |
Investing Cash Flow | -5.23 | -6.42 | -18.4 | -4.81 | 79.96 | -12.31 |
Short-Term Debt Issued | - | 128.57 | 149.59 | 31.45 | 55.11 | 100 |
Short-Term Debt Repaid | - | -145.76 | -146.7 | -54.64 | -44.11 | -148.4 |
Net Short-Term Debt Issued (Repaid) | - | -17.19 | 2.88 | -23.19 | 11 | -48.4 |
Long-Term Debt Issued | - | - | - | 150 | 20 | 170 |
Long-Term Debt Repaid | - | -0.93 | -0.71 | -123.69 | -86.41 | -114.13 |
Net Long-Term Debt Issued (Repaid) | - | -0.93 | -0.71 | 26.31 | -66.41 | 55.87 |
Issuance of Common Stock | -0 | 23.85 | 0.72 | 4.82 | - | - |
Repurchase of Common Stock | -1.47 | -1.27 | -0.15 | -0.27 | -0.79 | -0.41 |
Net Common Stock Issued (Repurchased) | -1.47 | 22.58 | 0.57 | 4.55 | -0.79 | -0.41 |
Issuance of Preferred Stock | - | - | - | 38.08 | - | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | 38.08 | - | - |
Other Financing Activities | -0.26 | 1.97 | 4.77 | -6.05 | -0.82 | -10.48 |
Financing Cash Flow | -5.64 | 6.42 | 7.51 | 39.7 | -57.02 | -3.42 |
Net Cash Flow | 4.22 | -0.2 | -10.63 | 17.45 | 0.35 | 0.74 |
Free Cash Flow | 6.35 | -13.62 | -18.14 | -38.92 | -52.53 | -8.75 |
FCF Margin | 5.02% | -10.57% | -14.14% | -37.69% | -47.21% | -8.68% |
Free Cash Flow Per Share | 0.17 | -0.39 | -0.49 | -1.30 | -1.78 | -0.30 |
Levered Free Cash Flow | -27.44 | -70.3 | 3.3 | -95.78 | -181.66 | -17.34 |
Unlevered Free Cash Flow | 13.26 | -25.05 | -19.89 | -21.03 | -23.6 | -12.07 |